High-plex Digital Spatial Profiling Identifies Subregion-Dependent Directed Proteome Changes Across Multiple Variants of Dementia
MacKenzie L. BoleniD, Kelly B. MeneesiD, Andrea R. MerchakiD, Marla GearingiD, Jingjing GongiD, Yuqi ReniD, Melissa Erin MurrayiD, Zachary T. McEachiniD, Malú G. TanseyiD
Abstract
Frontotemporal lobar degeneration (FTLD) is the leading cause of dementia in patients under the age of 65. Even in a single anatomical region, there is variance within pathological protein deposition as a result of FTLD. This spectrum of pathology leads to difficulty in identification of the disease during its progression and consequential varied post mortem clinicopathological diagnoses. NanoString GeoMx Digital Spatial Profiling (DSP) is a novel method that leverages the ability to spatially multiplex protein biomarkers of interest. We utilized NanoString DSP to investigate the proteome geography at two levels of the cortex and the subcortical white matter in patients with various types of dementia (Alzheimers disease, FTLD-c9ALS, FTLD-17, FTLD-TDP, FTLD-GRN; n=6 per syndrome) and neurologically healthy controls (NHC). Analysis of 75 different protein biomarkers of interest revealed both a disease and cortical subregion specific biomarker profile. Layers II-V of the cortex from diseased individuals displayed the greatest protein dysregulation as compared to NHC. Additionally, out of all disease groups within cortical layer 1, II-V and white matter, the FTLD-17 group had the most significant protein dysregulation as compared to NHC--specifically associated with immune cell pathways. Traditional biomarkers of dementia, such as various phosphorylated tau proteins and amyloid-{beta} 42 displayed dysregulation, however our data suggest spatial enrichment in distinct to cortical sublayers. In conclusion, we observed that depending on the variant of disease, specific protein deposits either span multiple levels of cortical geography or only a single layer. Thus, the specific localization of these deposits could potentially be used to elucidate region-specific pathologic biomarkers unique to individual variants of dementia.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-scale cerebrospinal fluid proteomics identifies diagnostic biomarker candidates across the clinico-pathological continuum of frontotemporal lobar degeneration
Rowan Saloner, Louisa Cornelis, … Adam L. Boxer·bioRxiv·Oct 8, 2026
- Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
Nicola Spotorno, Olof E. Lindberg, … Alexander Frizell Santillo·PLoS ONEPeer-reviewed·Oct 27, 2020
- Shared lipidome and proteome signatures of frontotemporal lobar degeneration and Alzheimer's disease
Yohannes Abere Ambaw, Alissa L. Nana, … Robert V. Farese·bioRxiv·Jul 11, 2026
- Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
William Richard Bevan-Jones, Thomas Cope, … James Benedict Rowe·BrainPeer-reviewed·Jan 27, 2020
- Cytoarchitectonic gradients of laminar degeneration in behavioral variant frontotemporal dementia
Daniel T. Ohm, Sharon Xiangwen Xie, … David John Irwin·BrainPeer-reviewed·Aug 9, 2024
- Quantitation of Spatial Proteoforms in Alzheimer's Disease
Daniel B. McClatchy, Natalie P. Turner, John R. Yates·bioRxiv·Jul 4, 2026